Recent studies have described progesterone-mediated RANKL signaling on ER/PR-negative epithelial stem and progenitor cell populations as a mechanism contributing to mammary tumorigenesis [19, 20]; however, the direct role of OPG on risk of developing BRCA-breast cancer has not been evaluated. This evidence concerns the gene TNFSF11 and breast cancer.